Key clinical point: The American Cancer Society endorsed two of the three main recommendations on human papillomavirus vaccination made by the Centers for Disease Control and Prevention.
Major finding: The ACS did not endorse the CDC recommendation for shared clinical decision-making regarding human papillomavirus vaccination in adults aged 27-45 years.
Study details: An ACS guidance based on a review of the CDC recommendations.
Disclosures: The ACS has received an educational grant from Merck Sharp & Dohme related to increasing human papillomavirus vaccination, but none of this paper’s authors are involved in those projects. Dr. Saslow is the principal investigator for a cooperative agreement between the ACS and CDC related to supporting human papillomavirus vaccination.
Saslow D et al. CA Cancer J Clin. 2020 Jul 8. doi: 10.3322/caac.21616.